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Introduction
MRSA remains one of the principal resistant pathogens
causing serious healthcare-associated and community-
onset infections [1]. This agent is associated with
increased morbidity, mortality risk and costs [2].
Objectives
Monitoring and control of MRSA cases in a high ende-
mic level scenario using multimodal strategy [3-5] in an
400 bed portuguese hospital.
Methods
Multistep procedure involving isolation measures and
active surveillance cultures (nasal swab using RT-PCR
detection technique) in a selected population (patients
from other hospitals and nursing homes; history of hos-
pitalization/ MRSA; ICU patients and, in other inpatient
services, direct contacts of newly detected MRSA
patients). Since 2012, this cultures are also applied to
patients doing hemodialysis. Other parallel activities: (a)
review of isolation and standard precautions policy, (b)
reinforcement of alcohol-based handrubs at point of
patient care, (c) information sessions to health profes-
sionals, (d) targeted information flyer for health profes-
sionals, (e) information leaflet for patients/ visitors; (f)
procedure monitoring by audit (g) patient decoloniza-
tion in ICU, with follow-up screenings.
Results
Between 2007 and 2012, MRSA surveillance detected a
decrease in proportion from 66% to 57% and in density
of incidence from 1.70 to 0,68 cases per thousand days
of hospitalization. According to published data from
EARSS, Portugal was the european country with the
highest level of MRSA in 2011 [6]. In this network
participated 22 portuguese hospitals and include 1507
isolates (blood and cerebrospinal fluid, only). Using this
inclusion criteria, our Hospital reveled a proportion of
MRSA below its national level (34% versus 55%) in
2011.
Conclusion
Fighting MRSA using a multimodal strategy is being
effective in a high endemic level hospital, but persever-
ance is needed through continuous surveillance of cases,
feed-back to professionals and procedure audits.
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